Wille Finance AG

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

Ultimate Medicine AG, a Swiss preclinical pharmaceutical company, is developing an innovative oral treatment for age-related cognitive disorders. Our approach targets an overlooked pathway complementing standard amyloid-β/tau therapies.